OREXIGEN
Live / Registered — Registered and renewed (as of 22 Mar 2018)
What this means for you
Registered since 11 Mar 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Mar 2018).
Record
- Serial number
- 78718907
- Registration number
- 3396021
- Mark type
- Design + words
- Filed
- 22 Sept 2005
- Published for opposition
- 18 Apr 2006
- Registered
- 11 Mar 2008
- Next maintenance due
- 11 Mar 2018
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF OBESITY, INDUCEMENT OF WEIGHT LOSS, AND PREVENTION OF WEIGHT GAIN
Owner
- NALPROPION PHARMACEUTICALS LLC, Brentwood, TN, US
- NALPROPION PHARMACEUTICALS, INC., MORRISTOWN, NJ, US
- Orexigen Therapeutics, Inc., La Jolla, CA, US
- Orexigen Therapeutics, Inc., San Diego, CA, US
- Orexigen Therapeutics, Inc., Laguna Niguel, CA, US
Prosecution history
- 27 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Aug 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Aug 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Mar 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Mar 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Mar 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Mar 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Mar 2018 — TEAS SECTION 8 & 9 RECEIVED
- 11 Mar 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED